Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,946
datasets available to search
ShareScore release 0.9.0
Dataset results
5,946 results for “diabetes type 2”
An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
ClinicalTrials.gov study NCT01064414. IPD Sharing: Not stated. Countries: 18. Publications: 3.
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)
ClinicalTrials.gov study NCT00905255. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT03014479. IPD Sharing: YES. Countries: 1. Publications: 1.
Impact of Structured Physical Activity Education Delivery in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02093702. IPD Sharing: NO. Countries: 1. Publications: 10.
A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes
ClinicalTrials.gov study NCT03993132. IPD Sharing: NO. Countries: 1. Publications: 1.
Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01673178. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT05700877. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
ClinicalTrials.gov study NCT00577824. IPD Sharing: Not stated. Countries: 1. Publications: 3.
U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod
ClinicalTrials.gov study NCT00606034. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01301833. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
ClinicalTrials.gov study NCT03653091. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)
ClinicalTrials.gov study NCT02354222. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
ClinicalTrials.gov study NCT01570751. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Study in Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01064687. IPD Sharing: Not stated. Countries: 4. Publications: 3.
A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control
ClinicalTrials.gov study NCT03242018. IPD Sharing: NO. Countries: 15. Publications: 2.
Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin
ClinicalTrials.gov study NCT03798080. IPD Sharing: YES. Countries: 1. Publications: 3.
Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT00924053. IPD Sharing: Not stated. Countries: 1. Publications: 14.
A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral
ClinicalTrials.gov study NCT02906917. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00971243. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol
ClinicalTrials.gov study NCT07255820. IPD Sharing: YES. Countries: 1. Publications: 8.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.